Cargando…

A Cell-Based Small Molecule Screening Method for Identifying Inhibitors of Epithelial-Mesenchymal Transition in Carcinoma

Epithelial Mesenchymal Transition (EMT) is a crucial mechanism for carcinoma progression, as it provides routes for in situ carcinoma cells to dissociate and become motile, leading to localized invasion and metastatic spread. Targeting EMT therefore represents an important therapeutic strategy for c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chua, Kian-Ngiap, Sim, Wen-Jing, Racine, Victor, Lee, Shi-Yun, Goh, Boon Cher, Thiery, Jean Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303807/ https://www.ncbi.nlm.nih.gov/pubmed/22432005 http://dx.doi.org/10.1371/journal.pone.0033183

Ejemplares similares

Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma
por: Chua, Kian Ngiap, et al.
Publicado: (2015)

Epithelial-mesenchymal transition as a mechanism for the progression of breast carcinoma
por: Thiery, JP, et al.
Publicado: (2011)

Epithelial to mesenchymal transition and breast cancer
por: Tomaskovic-Crook, Eva, et al.
Publicado: (2009)

Traditional Chinese Medicine and regulatory roles on epithelial–mesenchymal transitions
por: Bai, Jing, et al.
Publicado: (2019)

Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition
por: Zhao, Na, et al.
Publicado: (2021)

A zebrafish embryo screen utilizing gastrulation identifies the HTR2C inhibitor pizotifen as a suppressor of EMT-mediated metastasis
por: Nakayama, Joji, et al.
Publicado: (2021)

Host microenvironment in breast cancer development: Epithelial–mesenchymal transition in breast cancer development
por: Vincent-Salomon, Anne, et al.
Publicado: (2003)

Nanomaterials as Inhibitors of Epithelial Mesenchymal Transition in Cancer Treatment
por: Cordani, Marco, et al.
Publicado: (2019)

A pooled single-cell genetic screen identifies regulatory checkpoints in the continuum of the epithelial-to-mesenchymal transition
por: McFaline-Figueroa, José L., et al.
Publicado: (2019)

Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)
por: Huang, Ruby Yun-Ju, et al.
Publicado: (2015)

Narrative review: mesenchymal-epithelial transition inhibitors—meeting their target
por: Safi, Danish, et al.
Publicado: (2021)

Beyond just a tight fortress: contribution of stroma to epithelial-mesenchymal transition in pancreatic cancer
por: Bulle, Ashenafi, et al.
Publicado: (2020)

An epithelial marker promoter induction screen identifies histone deacetylase inhibitors to restore epithelial differentiation and abolishes anchorage independence growth in cancers
por: Tang, H M, et al.
Publicado: (2016)

YB-1 expression promotes epithelial-to-mesenchymal transition in prostate cancer that is inhibited by a small molecule fisetin
por: Khan, Mohammad Imran, et al.
Publicado: (2014)

Small molecule/ML327 mediated transcriptional de-repression of E-cadherin and inhibition of epithelial-to-mesenchymal transition
por: An, Hanbing, et al.
Publicado: (2015)

The Epithelial-to-Mesenchymal Transition in Cancer
por: Roche, Joëlle
Publicado: (2018)

Epithelial–mesenchymal transition in cancer
por: Moustakas, Aristidis, et al.
Publicado: (2017)

Cortactin in Epithelial–Mesenchymal Transition
por: Ji, Rong, et al.
Publicado: (2020)

Glycobiology of the Epithelial to Mesenchymal Transition
por: Pucci, Michela, et al.
Publicado: (2021)

Epithelial–Mesenchymal Transition (EMT)
por: Manfioletti, Guidalberto, et al.
Publicado: (2023)

Tetrandrine identified in a small molecule screen to activate mesenchymal stem cells for enhanced immunomodulation
por: Yang, Zijiang, et al.
Publicado: (2016)

Guidelines and definitions for research on epithelial–mesenchymal transition
por: Yang, Jing, et al.
Publicado: (2020)

The Zinc-Finger Protein Slug Causes Desmosome Dissociation, an Initial and Necessary Step for Growth Factor–induced Epithelial–Mesenchymal Transition
por: Savagner, Pierre, et al.
Publicado: (1997)

Interactions between epidermal growth factor receptor tyrosine kinase inhibitors and proton-pump inhibitors/histamine type-2 receptor antagonists in non-small cell lung cancer: a systematic review and meta-analysis
por: Sim, Wilson, et al.
Publicado: (2021)

SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition
por: Sundararajan, Vignesh, et al.
Publicado: (2019)

Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions
por: Guo, Fei, et al.
Publicado: (2014)

A small molecule screen identifies novel inhibitors of mechanosensory nematocyst discharge in Hydra
por: Hofmann, Diana, et al.
Publicado: (2021)

Forward genetic screens identify mechanisms of resistance to small molecule lactate dehydrogenase inhibitors
por: Frank, Anderson R, et al.
Publicado: (2023)

Small molecule screen identifies pyrimethamine as an inhibitor of NRF2-driven esophageal hyperplasia
por: Paiboonrungruang, Chorlada, et al.
Publicado: (2023)

Extracellular-Signal Regulated Kinase: A Central Molecule Driving Epithelial–Mesenchymal Transition in Cancer
por: Olea-Flores, Monserrat, et al.
Publicado: (2019)

Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells
por: NAGAHARA, TERUYA, et al.
Publicado: (2015)

The ROCK inhibitor, thiazovivin, inhibits human corneal endothelial-to-mesenchymal transition/epithelial-to-mesenchymal transition and increases ionic transporter expression
por: Wu, Qianni, et al.
Publicado: (2017)

Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells
por: Kong, Dejuan, et al.
Publicado: (2012)

Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells
por: Chen, Shuo, et al.
Publicado: (2018)

Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells
por: Chen, Shuo, et al.
Publicado: (2022)

Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
por: Tan, Tuan Zea, et al.
Publicado: (2014)

Monitoring Epithelial–Mesenchymal Transition of Pancreatic Cancer Cells via Investigation of Mitochondrial Dysfunction
por: Sim, Jae Jun, et al.
Publicado: (2020)

Clear Cell Renal Cell Carcinoma is linked to Epithelial‐to‐Mesenchymal Transition and to Fibrosis
por: Landolt, Lea, et al.
Publicado: (2017)

Epithelial mesenchymal transition (EMT) in small airways of COPD patients
por: Sohal, Sukhwinder Singh, et al.
Publicado: (2013)

Osteopontin—A Master Regulator of Epithelial-Mesenchymal Transition
por: Kothari, Anai N., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rcl0t1vardoiusruojn6esddtt